Xpress Biologics Overview

  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $715K
Latest Deal Amount
  • Investors
  • 3

Xpress Biologics General Information

Description

Operator of a contract manufacturing systems designed to provide services for pre-clinical productions. The company's systems include the design of microbial expression services, the development of the upstream and downstream processes, and the development of the quality controls for the production of recombinant proteins, antibody fragments, and plasmid DNA, enabling the vaccine, therapeutic and diagnostic markets to execute and manage clinical trials.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • Accessia Pharma site
  • Avenue du Parc Industriel, 89, Milmort
  • 4041 Herstal
  • Belgium
+32 04 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Xpress Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 22-Dec-2016 $715K 00.000 00.000 Completed Generating Revenue
2. Early Stage VC 14-Aug-2015 00000 00000 00000 Completed Generating Revenue
1. Accelerator/Incubator 01-Feb-2013 Completed Startup
To view Xpress Biologics’s complete valuation and funding history, request access »

Xpress Biologics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class C 0,000 0000.00 0000.00 00 0000.00 00.000
Class B 0,000 0000.00 0000.00 00 0000.00 00.000
Class A 000 0000.00 0000.00 00 0000.00 0.000
Class C 000 0000.00 0000.00 00 0000.00 0.000
Class B 1,300 $105.64 $105.64 1x $105.64 9.26%
Class A 1,211 $105.64 $105.64 1x $105.64 8.63%
To view Xpress Biologics’s complete cap table history, request access »

Xpress Biologics Executive Team (3)

Name Title Board Seat Contact Info
Marc Daukandt Co-Founder, Executive Director, Chief Executive Officer & Board Member
Philippe Ledent Ph.D Co-Founder, Board Member & Scientific Director
Christian Rodriguez Ph.D Co-Founder, Operation Director & Board Member
To view Xpress Biologics’s complete executive team members history, request access »

Xpress Biologics Board Members (2)

Name Representing Role Since
Christian Rodriguez Ph.D Xpress Biologics Co-Founder, Operation Director & Board Member 000 0000
Philippe Ledent Ph.D Xpress Biologics Co-Founder, Board Member & Scientific Director 000 0000
To view Xpress Biologics’s complete board members history, request access »

Xpress Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xpress Biologics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioWin Corporation Minority 000 0000 000000 0
Noshaq Venture Capital Minority 000 0000 000000 0
WBC Ventures Accelerator/Incubator Minority 000 0000 000000 0
To view Xpress Biologics’s complete investors history, request access »